tiprankstipranks
Advertisement
Advertisement
Lixte Biotechnology Announces At-the-Market Equity Financing
PremiumCompany AnnouncementsLixte Biotechnology Announces At-the-Market Equity Financing
22d ago
Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure
Premium
Company Announcements
Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure
26d ago
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Unlocking New Potential in Precision Cancer Treatment
Premium
TipRanks Newswire
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Unlocking New Potential in Precision Cancer Treatment
2M ago
Lixte Biotechnology presents preliminary LB100 results
PremiumThe FlyLixte Biotechnology presents preliminary LB100 results
2M ago
Lixte Biotech Holdings (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships
Premium
TipRanks Newswire
Lixte Biotech Holdings (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships
3M ago
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Files 2025 Form 10-K, Highlights Transformational Year
Premium
TipRanks Newswire
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Files 2025 Form 10-K, Highlights Transformational Year
3M ago
Landmark Proton Therapy Data Changes the Conversation; LIXTE Biotechnology (NASDAQ: LIXT) Saw It Coming
PremiumTipRanks NewswireLandmark Proton Therapy Data Changes the Conversation; LIXTE Biotechnology (NASDAQ: LIXT) Saw It Coming
3M ago
LIXTE Biotechnology (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape
Premium
TipRanks Newswire
LIXTE Biotechnology (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape
3M ago
Lixte Biotechnology Raises CEO Compensation Amid Leadership Support
Premium
Company Announcements
Lixte Biotechnology Raises CEO Compensation Amid Leadership Support
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100